Mitogens and the Cell Cycle
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 25, 2025

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
Yiming Xu1, Ziyi Bai1, Tianxia Lan1
1Department of Biotherapy Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University Chengdu Sichuan China.
CD44, a cell surface receptor, has standard (CD44s) and variant (CD44v) isoforms that play complex roles in cancer progression. Understanding these CD44 isoforms is crucial for developing targeted cancer therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: